 | • レポートコード：GIR-105X01058 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗凝固作用拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗凝固作用拮抗薬の種類別市場規模（プロトロンビン複合体濃縮物、ビタミンK、プロタミン、トラネキサム酸）、用途別市場規模（病院薬局、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗凝固作用拮抗薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bausch Health Companies、Pfizer、Fresenius Kabi、Amneal Pharmaceuticals、Boehringer Ingelheim、CSL、Octapharma、Portola Pharmaceuticals、Perosphere Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロトロンビン複合体濃縮物、ビタミンK、プロタミン、トラネキサム酸 ・用途別分析2016年-2026年：病院薬局、小売薬局、その他 ・抗凝固作用拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗凝固作用拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗凝固作用拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗凝固作用拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗凝固作用拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anticoagulant Reversal Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anticoagulant Reversal Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anticoagulant Reversal Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anticoagulant Reversal Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Others
The key market players for global Anticoagulant Reversal Drug market are listed below:
Bausch Health Companies
Pfizer
Fresenius Kabi
Amneal Pharmaceuticals
Boehringer Ingelheim
CSL
Octapharma
Portola Pharmaceuticals
Perosphere Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anticoagulant Reversal Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticoagulant Reversal Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prothrombin Complex Concentrates
1.2.3 Vitamin K
1.2.4 Protamine
1.2.5 Tranexamic Acid
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticoagulant Reversal Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Anticoagulant Reversal Drug Market Size & Forecast
1.4.1 Global Anticoagulant Reversal Drug Sales in Value (2016-2026))
1.4.2 Global Anticoagulant Reversal Drug Sales in Volume (2016-2026)
1.4.3 Global Anticoagulant Reversal Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Anticoagulant Reversal Drug Production Capacity Analysis
1.5.1 Global Anticoagulant Reversal Drug Total Production Capacity (2016-2026)
1.5.2 Global Anticoagulant Reversal Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anticoagulant Reversal Drug Market Drivers
1.6.2 Anticoagulant Reversal Drug Market Restraints
1.6.3 Anticoagulant Reversal Drug Trends Analysis
2 Manufacturers Profiles
2.1 Bausch Health Companies
2.1.1 Bausch Health Companies Details
2.1.2 Bausch Health Companies Major Business
2.1.3 Bausch Health Companies Anticoagulant Reversal Drug Product and Services
2.1.4 Bausch Health Companies Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Anticoagulant Reversal Drug Product and Services
2.2.4 Pfizer Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Anticoagulant Reversal Drug Product and Services
2.3.4 Fresenius Kabi Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Amneal Pharmaceuticals
2.4.1 Amneal Pharmaceuticals Details
2.4.2 Amneal Pharmaceuticals Major Business
2.4.3 Amneal Pharmaceuticals Anticoagulant Reversal Drug Product and Services
2.4.4 Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Anticoagulant Reversal Drug Product and Services
2.5.4 Boehringer Ingelheim Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Anticoagulant Reversal Drug Product and Services
2.6.4 CSL Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Octapharma
2.7.1 Octapharma Details
2.7.2 Octapharma Major Business
2.7.3 Octapharma Anticoagulant Reversal Drug Product and Services
2.7.4 Octapharma Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Portola Pharmaceuticals
2.8.1 Portola Pharmaceuticals Details
2.8.2 Portola Pharmaceuticals Major Business
2.8.3 Portola Pharmaceuticals Anticoagulant Reversal Drug Product and Services
2.8.4 Portola Pharmaceuticals Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Perosphere Pharmaceuticals
2.9.1 Perosphere Pharmaceuticals Details
2.9.2 Perosphere Pharmaceuticals Major Business
2.9.3 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product and Services
2.9.4 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anticoagulant Reversal Drug Sales by Manufacturer
3.1 Global Anticoagulant Reversal Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anticoagulant Reversal Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anticoagulant Reversal Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Anticoagulant Reversal Drug Manufacturer Market Share
3.4.2 Top 6 Anticoagulant Reversal Drug Manufacturer Market Share
3.5 Global Anticoagulant Reversal Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anticoagulant Reversal Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anticoagulant Reversal Drug Market Size by Region
4.1.1 Global Anticoagulant Reversal Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Anticoagulant Reversal Drug Revenue by Region (2016-2026)
4.2 North America Anticoagulant Reversal Drug Revenue (2016-2026)
4.3 Europe Anticoagulant Reversal Drug Revenue (2016-2026)
4.4 Asia-Pacific Anticoagulant Reversal Drug Revenue (2016-2026)
4.5 South America Anticoagulant Reversal Drug Revenue (2016-2026)
4.6 Middle East and Africa Anticoagulant Reversal Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anticoagulant Reversal Drug Sales in Volume by Type (2016-2026)
5.2 Global Anticoagulant Reversal Drug Revenue by Type (2016-2026)
5.3 Global Anticoagulant Reversal Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anticoagulant Reversal Drug Sales in Volume by Application (2016-2026)
6.2 Global Anticoagulant Reversal Drug Revenue by Application (2016-2026)
6.3 Global Anticoagulant Reversal Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anticoagulant Reversal Drug Sales by Type (2016-2026)
7.2 North America Anticoagulant Reversal Drug Sales by Application (2016-2026)
7.3 North America Anticoagulant Reversal Drug Market Size by Country
7.3.1 North America Anticoagulant Reversal Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Anticoagulant Reversal Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anticoagulant Reversal Drug Sales by Type (2016-2026)
8.2 Europe Anticoagulant Reversal Drug Sales by Application (2016-2026)
8.3 Europe Anticoagulant Reversal Drug Market Size by Country
8.3.1 Europe Anticoagulant Reversal Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Anticoagulant Reversal Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anticoagulant Reversal Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Anticoagulant Reversal Drug Market Size by Region
9.3.1 Asia-Pacific Anticoagulant Reversal Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anticoagulant Reversal Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anticoagulant Reversal Drug Sales by Type (2016-2026)
10.2 South America Anticoagulant Reversal Drug Sales by Application (2016-2026)
10.3 South America Anticoagulant Reversal Drug Market Size by Country
10.3.1 South America Anticoagulant Reversal Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Anticoagulant Reversal Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anticoagulant Reversal Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Anticoagulant Reversal Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Anticoagulant Reversal Drug Market Size by Country
11.3.1 Middle East & Africa Anticoagulant Reversal Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anticoagulant Reversal Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anticoagulant Reversal Drug Typical Distributors
12.3 Anticoagulant Reversal Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anticoagulant Reversal Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anticoagulant Reversal Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table 4. Bausch Health Companies Major Business
Table 5. Bausch Health Companies Anticoagulant Reversal Drug Product and Services
Table 6. Bausch Health Companies Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Anticoagulant Reversal Drug Product and Services
Table 10. Pfizer Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 12. Fresenius Kabi Major Business
Table 13. Fresenius Kabi Anticoagulant Reversal Drug Product and Services
Table 14. Fresenius Kabi Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Amneal Pharmaceuticals Major Business
Table 17. Amneal Pharmaceuticals Anticoagulant Reversal Drug Product and Services
Table 18. Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Anticoagulant Reversal Drug Product and Services
Table 22. Boehringer Ingelheim Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. CSL Basic Information, Manufacturing Base and Competitors
Table 24. CSL Major Business
Table 25. CSL Anticoagulant Reversal Drug Product and Services
Table 26. CSL Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Octapharma Basic Information, Manufacturing Base and Competitors
Table 28. Octapharma Major Business
Table 29. Octapharma Anticoagulant Reversal Drug Product and Services
Table 30. Octapharma Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Portola Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Portola Pharmaceuticals Major Business
Table 33. Portola Pharmaceuticals Anticoagulant Reversal Drug Product and Services
Table 34. Portola Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Perosphere Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Perosphere Pharmaceuticals Major Business
Table 37. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product and Services
Table 38. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Anticoagulant Reversal Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Anticoagulant Reversal Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Anticoagulant Reversal Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Anticoagulant Reversal Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Anticoagulant Reversal Drug Production Site of Key Manufacturer
Table 44. Global Anticoagulant Reversal Drug Sales by Region (2016-2021e) & (K Units)
Table 45. Global Anticoagulant Reversal Drug Sales by Region (2021-2026) & (K Units)
Table 46. Global Anticoagulant Reversal Drug Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Anticoagulant Reversal Drug Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Anticoagulant Reversal Drug Sales by Type (2016-2021e) & (K Units)
Table 49. Global Anticoagulant Reversal Drug Sales by Type (2021-2026) & (K Units)
Table 50. Global Anticoagulant Reversal Drug Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Anticoagulant Reversal Drug Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Anticoagulant Reversal Drug Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Anticoagulant Reversal Drug Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Anticoagulant Reversal Drug Sales by Application (2016-2021e) & (K Units)
Table 55. Global Anticoagulant Reversal Drug Sales by Application (2021-2026) & (K Units)
Table 56. Global Anticoagulant Reversal Drug Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Anticoagulant Reversal Drug Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Anticoagulant Reversal Drug Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Anticoagulant Reversal Drug Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Anticoagulant Reversal Drug Sales by Country (2016-2021e) & (K Units)
Table 61. North America Anticoagulant Reversal Drug Sales by Country (2021-2026) & (K Units)
Table 62. North America Anticoagulant Reversal Drug Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Anticoagulant Reversal Drug Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Anticoagulant Reversal Drug Sales by Type (2016-2021e) & (K Units)
Table 65. North America Anticoagulant Reversal Drug Sales by Type (2021-2026) & (K Units)
Table 66. North America Anticoagulant Reversal Drug Sales by Application (2016-2021e) & (K Units)
Table 67. North America Anticoagulant Reversal Drug Sales by Application (2021-2026) & (K Units)
Table 68. Europe Anticoagulant Reversal Drug Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Anticoagulant Reversal Drug Sales by Country (2021-2026) & (K Units)
Table 70. Europe Anticoagulant Reversal Drug Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Anticoagulant Reversal Drug Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Anticoagulant Reversal Drug Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Anticoagulant Reversal Drug Sales by Type (2021-2026) & (K Units)
Table 74. Europe Anticoagulant Reversal Drug Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Anticoagulant Reversal Drug Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Anticoagulant Reversal Drug Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Anticoagulant Reversal Drug Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Anticoagulant Reversal Drug Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Anticoagulant Reversal Drug Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Anticoagulant Reversal Drug Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Anticoagulant Reversal Drug Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2021-2026) & (K Units)
Table 84. South America Anticoagulant Reversal Drug Sales by Country (2016-2021e) & (K Units)
Table 85. South America Anticoagulant Reversal Drug Sales by Country (2021-2026) & (K Units)
Table 86. South America Anticoagulant Reversal Drug Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Anticoagulant Reversal Drug Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Anticoagulant Reversal Drug Sales by Type (2016-2021e) & (K Units)
Table 89. South America Anticoagulant Reversal Drug Sales by Type (2021-2026) & (K Units)
Table 90. South America Anticoagulant Reversal Drug Sales by Application (2016-2021e) & (K Units)
Table 91. South America Anticoagulant Reversal Drug Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Anticoagulant Reversal Drug Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Anticoagulant Reversal Drug Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Anticoagulant Reversal Drug Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Anticoagulant Reversal Drug Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Anticoagulant Reversal Drug Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Anticoagulant Reversal Drug Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Anticoagulant Reversal Drug Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Anticoagulant Reversal Drug Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Anticoagulant Reversal Drug Typical Distributors
Table 103. Anticoagulant Reversal Drug Typical Customers
List of Figures
Figure 1. Anticoagulant Reversal Drug Picture
Figure 2. Global Anticoagulant Reversal Drug Sales Market Share by Type in 2020
Figure 3. Prothrombin Complex Concentrates
Figure 4. Vitamin K
Figure 5. Protamine
Figure 6. Tranexamic Acid
Figure 7. Global Anticoagulant Reversal Drug Sales Market Share by Application in 2020
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Others
Figure 11. Global Anticoagulant Reversal Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Anticoagulant Reversal Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Anticoagulant Reversal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Anticoagulant Reversal Drug Sales (2016-2026) & (K Units)
Figure 33. Global Anticoagulant Reversal Drug Production Capacity (2016-2026) & (K Units)
Figure 34. Global Anticoagulant Reversal Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Anticoagulant Reversal Drug Market Drivers
Figure 36. Anticoagulant Reversal Drug Market Restraints
Figure 37. Anticoagulant Reversal Drug Market Trends
Figure 38. Global Anticoagulant Reversal Drug Sales Market Share by Manufacturer in 2020
Figure 39. Global Anticoagulant Reversal Drug Revenue Market Share by Manufacturer in 2020
Figure 40. Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Anticoagulant Reversal Drug Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Anticoagulant Reversal Drug Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Anticoagulant Reversal Drug Sales Market Share by Region (2016-2026)
Figure 44. Global Anticoagulant Reversal Drug Revenue Market Share by Region (2016-2026)
Figure 45. North America Anticoagulant Reversal Drug Revenue (2016-2026) & (USD Million)
Figure 46. Europe Anticoagulant Reversal Drug Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Anticoagulant Reversal Drug Revenue (2016-2026) & (USD Million)
Figure 48. South America Anticoagulant Reversal Drug Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Anticoagulant Reversal Drug Revenue (2016-2026) & (USD Million)
Figure 50. Global Anticoagulant Reversal Drug Sales Market Share by Type (2016-2026)
Figure 51. Global Anticoagulant Reversal Drug Revenue Market Share by Type (2016-2026)
Figure 52. Global Anticoagulant Reversal Drug Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Anticoagulant Reversal Drug Sales Market Share by Application (2016-2026)
Figure 54. Global Anticoagulant Reversal Drug Revenue Market Share by Application (2016-2026)
Figure 55. Global Anticoagulant Reversal Drug Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Anticoagulant Reversal Drug Sales Market Share by Country (2016-2026)
Figure 57. North America Anticoagulant Reversal Drug Revenue Market Share by Country (2016-2026)
Figure 58. North America Anticoagulant Reversal Drug Sales Market Share by Type (2016-2026)
Figure 59. North America Anticoagulant Reversal Drug Sales Market Share by Application (2016-2026)
Figure 60. Europe Anticoagulant Reversal Drug Sales Market Share by Country (2016-2026)
Figure 61. Europe Anticoagulant Reversal Drug Revenue Market Share by Country (2016-2026)
Figure 62. Europe Anticoagulant Reversal Drug Sales Market Share by Type (2016-2026)
Figure 63. Europe Anticoagulant Reversal Drug Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Anticoagulant Reversal Drug Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Anticoagulant Reversal Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Anticoagulant Reversal Drug Revenue Market Share by Country (2016-2026)
Figure 70. South America Anticoagulant Reversal Drug Sales Market Share by Type (2016-2026)
Figure 71. South America Anticoagulant Reversal Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Anticoagulant Reversal Drug Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Anticoagulant Reversal Drug Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Anticoagulant Reversal Drug Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Anticoagulant Reversal Drug Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の直接経口抗凝固薬市場 2021：企業別、地域別、種類・用途別 The Direct Oral Anticoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界のプロトロンビン複合体濃縮物市場 2021：企業別、地域別、種類・用途別 The Prothrombin Complex Concentrates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 抗凝固剤の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for…
- 世界の乾癬性関節炎治療薬市場 2021：企業別、地域別、種類・用途別 The Psoriatic Arthritis Therapeutics Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 暴食疾患用薬の世界市場2018-2025 Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusuall…